NR1H2 and melanoma: Previous studies have shown that pharmacological activation of ubiquitously expressed LXRβ significantly upregulates APOE expression and suppresses melanoma tumor progression (Bensinger et al, 2008; Fontaine et al, 2007; Zelcer et al, 2007).